These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37847237)

  • 21. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents.
    Pillunat LE; Erb C; Jünemann AG; Kimmich F
    Clin Ophthalmol; 2017; 11():1583-1600. PubMed ID: 28919702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It?
    Sheheitli H; Tirpack AR; Parrish RK
    Asia Pac J Ophthalmol (Phila); 2019; 8(6):436-440. PubMed ID: 31789645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma.
    Foo VHX; Htoon HM; Welsbie DS; Perera SA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011875. PubMed ID: 30999387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
    Babizhayev MA
    Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimally invasive glaucoma surgery: current implants and future innovations.
    SooHoo JR; Seibold LK; Radcliffe NM; Kahook MY
    Can J Ophthalmol; 2014 Dec; 49(6):528-33. PubMed ID: 25433743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New concepts for glaucoma implants--controlled aqueous humor drainage, encapsulation prevention and local drug delivery.
    Schmidt W; Kastner C; Sternberg K; Allemann R; Löbler M; Guthoff R; Schmitz KP
    Curr Pharm Biotechnol; 2013; 14(1):98-111. PubMed ID: 23092262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
    Rao PV; Pattabiraman PP; Kopczynski C
    Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parylene-C Microbore Tubing: A Simpler Shunt for Reducing Intraocular Pressure.
    Collar B; Shah J; Cox A; Simon G; Irazoqui P
    IEEE Trans Biomed Eng; 2022 Mar; 69(3):1264-1272. PubMed ID: 34714731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suprachoroidal devices in glaucoma surgery.
    Kammer JA; Mundy KM
    Middle East Afr J Ophthalmol; 2015; 22(1):45-52. PubMed ID: 25624673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanylate cyclase activators, cell volume changes and IOP reduction.
    Ellis DZ
    Cell Physiol Biochem; 2011; 28(6):1145-54. PubMed ID: 22179003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modified scleral dissection technique with suprachoroidal drainage for canaloplasty.
    Szurman P; Januschowski K; Boden KT; Szurman GB
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):351-4. PubMed ID: 26666231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable drainage devices in glaucoma: Quo vadis?
    Yadav KS; Sharma S
    Eur J Pharm Sci; 2019 May; 133():1-7. PubMed ID: 30877069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological analysis of trabeculotomy - An investigation on the intraocular pressure lowering mechanism.
    Hamanaka T; Chin S; Shinmei Y; Sakurai T; Tanito M; Kijima R; Tsutsui A; Ueno Y; Ishida N; Ueda T; Kumasaka T
    Exp Eye Res; 2022 Jun; 219():109079. PubMed ID: 35439528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma.
    Hao H; He B; Yu B; Yang J; Xing X; Liu W
    Biomater Adv; 2022 Nov; 142():213162. PubMed ID: 36279749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. iStent with Phacoemulsification versus Phacoemulsification Alone for Patients with Glaucoma and Cataract: A Meta-Analysis.
    Malvankar-Mehta MS; Iordanous Y; Chen YN; Wang WW; Patel SS; Costella J; Hutnik CM
    PLoS One; 2015; 10(7):e0131770. PubMed ID: 26147908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrobulbar tube shunt: anterior chamber to back of the eye (A2B) efficacy in glaucomatous eyes with uncontrolled IOP.
    Montelongo M; de Ribot FM; Craven ER; Sponsel WE
    Graefes Arch Clin Exp Ophthalmol; 2021 Mar; 259(3):705-714. PubMed ID: 33175221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling and characterization of a valved glaucoma drainage device with implications for enhanced therapeutic efficacy.
    Pan T; Stay MS; Barocas VH; Brown JD; Ziaie B
    IEEE Trans Biomed Eng; 2005 May; 52(5):948-51. PubMed ID: 15887547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of trace elements on the therapeutic success of suprachoroidal draining devices.
    Wörn M; Lämmer R; Lucio M; Michalke B; Rühl E; Hohberger B
    J Trace Elem Med Biol; 2023 Jul; 78():127195. PubMed ID: 37207415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous intraocular pressure (IOP) measurement during glaucoma drainage device implantation.
    Gouws P; Moss EB; Trope GE; Ethier CR
    J Glaucoma; 2007 May; 16(3):329-33. PubMed ID: 17438429
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.